Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alexion Pharmaceuticals Inc

+ Add to Watchlist

ALXN:US

180.3600 USD 2.4000 1.31%

As of 20:10:00 ET on 01/27/2015.

Company Profile for Alexion Pharmaceuticals Inc (ALXN)

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.

Contact Information

Alexion Pharmaceuticals Inc

352 Knotter Drive
Cheshire, CT 06410
United States
Phone: 1-203-272-2596
Fax: 1-203-271-8198

Key Executives for Alexion Pharmaceuticals Inc (ALXN)

Leonard BellCEO/Treasurer/Co-FounderDavid L HallalChief Operating Officer
Vikas SinhaExec VP/CFOClare CarmichaelExec VP/Chief Human Resource Ofcr
John B Moriarty JrExec VP/General CounselMartin MackayExec VP/Head:Research & Dev
Julie O'NeillExec VP:Global OpsEdward MillerSenior VP/Chief Compliance Ofcr
Saqib IslamSenior VP/Chief Strategy OfcrElena RidloffExec Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil